secwatch.observer — SEC 8-K summary
======================================

Issuer:     Integer Holdings Corp (ITGR)
CIK:        0001114483
Form:       8-K
Filed at:   2022-04-28T23:59:59+00:00
Accession:  0001171843-22-002915
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Integer Q1 sales up 7% to $311M, adjusted EPS down 20%; guidance raised for Aran Biomedical acquisition
--------------------------------------------------------------------------------

- Sales $311M (+7% YoY); GAAP net income $11M (-47%); adjusted net income $26M (-19%).
- GAAP diluted EPS $0.34; non-GAAP adjusted EPS $0.78, down 20% YoY.
- Acquired Aran Biomedical on April 6, 2022; adds ~$90M annualized sales at accretive growth.
- FY2022 outlook: sales $1.36-1.38B (11-13% growth), adj. EBITDA $273-285M (12-17% growth).
- Cardio & Vascular sales +13%; Cardiac Rhythm +1%; Electrochem +18%; Advanced Surgical -2%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1114483/000117184322002915/0001171843-22-002915-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1114483/000117184322002915/f8k_042822.htm
  HTML page:      https://secwatch.observer/filing/0001171843-22-002915

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer